The multifaceted role of IDO1 in CRC, from immune tolerance and prognostic implications to intricate molecular pathways and potential therapeutic interventions, underscores the complexity of this enzyme in the context of cancer biology. The gene discussed is IDO1; the disease is colorectal carcinoma.